Clients express warm approval of Stuart Bressman, describing him as “one of the most creative capital markets lawyers in New York” and praising his “deep experience and understanding of the full range of capital markets transactions.”
Chambers USA 2018
Stuart advises investment banks and issuers on public and private securities offerings by US and non-US companies. Clients also seek him out for his market-leading experience in alternative financing techniques, such as confidentially marketed public offerings, bought deals, registered direct offerings and private investments in public equity. Over his career, Stuart has completed hundreds of public offerings and private placements of securities as well as other kinds of transactions.
Stuart has particular experience across the biotechnology, pharmaceutical, technology and energy industries, and advises clients on corporate and securities compliance and reporting matters.
Experience
Representation of Citigroup, Cowen and Leerink on several public offerings of securities, at-the-market offering programs and private placements by Kura Oncology, including an aggregate of $142 million in common stock offerings, a $75 million ATM program and a $60 million offering in connection with a reverse merger into a public shell.*
Representation of J.P. Morgan and Leerink on several public offerings of common stock by Intra-Cellular Therapies, Inc. totaling $732 million in the aggregate, including a $107 million initial registered offering following a merger into a public shell.*
Representation of Cowen and Company on a public offering of $72.5 million of common stock by Sangamo Therapeutics.*
Representation of Oppenheimer and Stifel Nicolaus on several public securities offerings by FuelCell Energy, including a $33 million preferred stock offering, a $16 million common stock and warrants offering, and a $32 million common stock offering.*
Representation of Bank of America Merrill Lynch, J.P. Morgan and Cowen on a $230 million common stock offering by Sangamo Therapeutics, Inc.*
Representation of Citigroup on a $115 million common stock offering by Vanda Pharmaceuticals.*
Representation of J.P. Morgan on a $200 million Rule 144A convertible senior notes offering by ARIAD Pharmaceuticals.*
* Matters prior to joining White & Case
Chambers USA: Nationwide: Capital Markets: Debt & Equity 2009 – 2018
Chambers Global: USA: Capital Markets: Debt & Equity 2009 – 2018
New York Super Lawyers 2006 – 2018
